Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural characterization of dicyanopyridine containing DNMT1-selective, non-nucleoside inhibitors
J.R. Horton, Sarath Pathuri, Kristen Wong, et al.
Structure (2022) Vol. 30, Iss. 6, pp. 793-802.e5
Open Access | Times Cited: 21

Showing 21 citing articles:

Methylation across the central dogma in health and diseases: new therapeutic strategies
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 40
Non-nucleoside inhibitors of DNMT1 and DNMT3 for targeted cancer therapy
Ting Chen, Syrine Mahdadi, Michel Vidal, et al.
Pharmacological Research (2024) Vol. 207, pp. 107328-107328
Open Access | Times Cited: 7
GSK-3484862 targets DNMT1 for degradation in cells
Qin Chen, Bigang Liu, Yang Zeng, et al.
NAR Cancer (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 18
Discovery of potent DNMT1 inhibitors against sickle cell disease using structural-based virtual screening, MM-GBSA and molecular dynamics simulation-based approaches
Ala Chandu, Renuka Parshuram Joshi, Pragya Gupta, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 1, pp. 261-273
Open Access | Times Cited: 7
Consensus docking aid to model the activity of an inhibitor of DNA methyltransferase 1 inspired by de novo design
Diana L. Prado‐Romero, Alejandro Gómez‐García, Raziel Cedillo-González, et al.
Frontiers in Drug Discovery (2023) Vol. 3
Open Access | Times Cited: 7
Identification of a potential DNA methyltransferase (DNMT) inhibitor
Zainab Jan, Wesam S. Ahmed, Kabir H. Biswas, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 9, pp. 4730-4744
Open Access | Times Cited: 6
C2H2 Zinc Finger Transcription Factors Associated with Hemoglobinopathies
Xing Zhang, Fangfang Xia, Xiaotian Zhang, et al.
Journal of Molecular Biology (2023) Vol. 436, Iss. 7, pp. 168343-168343
Open Access | Times Cited: 5
Structural insight into the DNMT1 reaction cycle by cryo-electron microscopy
Inessa De, Jonas Weidenhausen, N.O. Concha, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0307850-e0307850
Open Access | Times Cited: 1
Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity
Yingjie Chang, Huahui Guo, Xue Li, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
3,5-Dicyanopyridine motifs for electron-transporting semiconductors: from design and synthesis to efficient organic light-emitting diodes
Karolis Leitonas, Brigita Vı̄gante, Dmytro Volyniuk, et al.
Journal of Materials Chemistry C (2023) Vol. 11, Iss. 28, pp. 9514-9526
Closed Access | Times Cited: 4
Assigning functionality to cysteines by base editing of cancer dependency genes
Haoxin Li, Jarrett R. Remsberg, Sang Joon Won, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Systematic Design of Adenosine Analogs as Inhibitors of a Clostridioides difficile-Specific DNA Adenine Methyltransferase Required for Normal Sporulation and Persistence
Jujun Zhou, J.R. Horton, Martina Menna, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 934-950
Open Access | Times Cited: 7
Mediating and maintaining methylation while minimizing mutation: Recent advances on mammalian DNA methyltransferases
Xiaodong Cheng, Robert Blumenthal
Current Opinion in Structural Biology (2022) Vol. 75, pp. 102433-102433
Open Access | Times Cited: 6
Quinoline-based compounds can inhibit diverse enzymes that act on DNA
Jujun Zhou, Qin Chen, Ren Ren, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Cytosine analogues as DNA methyltransferase substrates
Marek Wojciechowski, H. Czapinska, Joanna Krwawicz, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 15, pp. 9267-9281
Open Access
DNA methylation protects cancer cells against non-canonical senescence
Xiaoying Chen, Kosuke Yamaguchi, Brianna Rodgers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Toward Understanding Pharmacological Modulation of DNA Methylation
J.R. Horton
Royal Society of Chemistry eBooks (2024), pp. 193-227
Closed Access
Drug Discovery for Chromatin Readers, Writers, Erasers, Remodelers and Epitranscriptomic Targets

Royal Society of Chemistry eBooks (2024)
Closed Access
Quinoline-based compounds can inhibit diverse enzymes that act on DNA
Jujun Zhou, Qin Chen, Ren Ren, et al.
Cell chemical biology (2024)
Open Access
Perspectives on materials: Reality and potential of epigenetic drug nano-delivery
Yunxiang Zhang, Derui Xu, Xianglin Hou, et al.
Chemical Engineering Journal (2024), pp. 157746-157746
Closed Access
GSK-3484862 targets DNMT1 for degradation in cells
Qin Chen, Yang Zeng, Jee Won Hwang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Page 1

Scroll to top